COMP <GO>
ENSG vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
The Ensign Group Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ENSG 2
— MRK 12
■ METRIC PARITY
LAST: $179.06 (-1.35%) • MKT CAP: $10.59B
options-implied-move
—
LAST: $148.36 (-0.78%) • MKT CAP: $368.89B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENSG VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ENSG | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.10% | 74.80% | -54.70 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.00% | 20.70% | -2.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 15.3x | +1.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.11% | 3.42% | -0.31 | MRK | /fcf-yield <GO> |
| Operating Margin | 8.50% | 34.30% | -25.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 6.80% | 28.10% | -21.30 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 1.30% | +17.50 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.13% | 2.26% | -2.13 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.73 | 5.19 | -1.46 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ENSG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.1 | 56.3 | -2.20 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 0.92 | -0.03 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 18.4x | +8.10 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.59B | $368.89B | -$358.30B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ENSG REV | MRK REV | ENSG GROSS % | MRK GROSS % | ENSG FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.03B | $65.01B | 20.1% | 74.8% | $337.8M | $12.36B |
| FY 2024 | $4.24B | $64.17B | 20.3% | 76.3% | $156.5M | $18.10B |
| FY 2023 | $3.71B | $60.12B | — | — | $209.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENSG // BETA 0.89
MRK // BETA 0.92